[Skip to Navigation]
Sign In
Correction
September 30, 2021

Omitted Conflict of Interest Statement

JAMA Oncol. 2021;7(11):1729. doi:10.1001/jamaoncol.2021.5334

In the Viewpoint “Is It Time to Reevaluate Radiotherapy Omission in Older Patients With Favorable Early-Stage Breast Cancer?”1 and Letter in Reply “Omission of Radiotherapy in Older Adults With Early-Stage Breast Cancer—Reply,”2 published in JAMA Oncology, author Arpit M. Chhabra, MD, omitted the following from his conflict of interest disclosures: “Dr Chhabra reports receiving consulting fees from SDX Respiratory Gating System and a speaking fee from icotec Medical Inc (both of which provide products or equipment for use in radiotherapy) and a stipend for reviewing charts for the American College of Radiation Oncology Accreditation Program.” The articles have been corrected to add these disclosures.

References
1.
Chowdhary  M, Chhabra  AM, Jhawar  SR.  Is it time to reevaluate radiotherapy omission in older patients with favorable early-stage breast cancer?   JAMA Oncol. 2021;7(7):965-966. doi:10.1001/jamaoncol.2021.0064PubMedGoogle ScholarCrossref
2.
Chowdhary  M, Chhabra  AM, Jhawar  SR.  Omission of radiotherapy in older adults with early-stage breast cancer–reply.   JAMA Oncol. 2021. Published online July 22, 2021. doi:10.1001/jamaoncol.2021.2407PubMedGoogle Scholar
×